Thompson Davis & Co., Inc. Assembly Biosciences, Inc. Transaction History

Thompson Davis & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 03, 2018	SELL	$39.21 - $50.29 $4,901 - $6,286	-125 Closed	0 $0
Q4 2017 Feb 05, 2018	SELL	$28.58 - $49.91 $10,717 - $18,716	-375 Reduced 75.0%	125 $6,000
Q3 2017 Oct 30, 2017	BUY	$23.08 - $34.92 $11,540 - $17,460	500	500 $17,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $782M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.